A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors
Clinical trial NCT06487858 · TERMINATED
Trial details
- NCT number
- NCT06487858
- Sponsor
- BeOne Medicines
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-16
- Primary completion
- 2026-04-09
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.